+++++++++++++++++++++++++++++++++++++++++++++++++
Posted Wed, 21 Dec 2022 12:50:11
This message was forwarded through MEDSOCNEWS.
If you wish to make an announcement or publicise
an event then please send the text to:
[log in to unmask]
You can follow the BSA MedSoc Group on @BSAMedsoc
You can follow the BSA funded blog on
health in times of austerity on @Cost_ofLiving
+++++++++++++++++++++++++++++++++++++++++++++++++
*Webinar on Challenging Pharmaceutical Innovation*
Public-private-patient partnerships, compounding or magistral preparation,
and academic development of pharmaceuticals: alternatives to the classical
pharmaceutical innovation model have taken off (again) since the turn of
the century. Actors driving them include patients, clinicians, and
pharmacists, often supported by healthcare insurers and policymakers at
national and international levels.
Generally, these new ways of organising pharmaceutical innovation respond
to well-known availability, accessibility, and affordability problems that
increasingly dominate pharmaceutical spaces across the globe.
To make these initiatives successful, people take on new-to-them roles or
join hands with others in partnerships. They are, as such, examples of
*social *innovation. These social pharmaceutical innovation (SPIN)
initiatives are strongly context-dependent and remain loosely connected, if
at all (Douglas et al., 2022). At the same time, the experienced problems
that SPINs seek to address are remarkably similar across different
contexts. Given these factors, there is enormous potential in sharing
experiences to promote patient access to medicines.
On *9 February 2023 from 16:00-17:30 CET*, the Global Pharmaceuticals &
Society Studies Network will devote its kick-off webinar to introducing you
to several social innovation alternatives and how they challenge current
modes of organising pharmaceutical innovation. Confirmed speakers include
Stephanie Michaud (BioCanRX, Canada).
The GPSS network aims to stimulate cross-national knowledge exchange and
build a community to provide for collaborations in critical pharmaceutical
studies. We seek to facilitate reflection and critical discussion on
political, economic, social, and ethical issues related to pharmaceutical
development, production, marketing, use, and regulation.
Please register for our kick-off webinar or indicate your interest in
future GPSS network activities via the Google Form here
<https://docs.google.com/forms/d/e/1FAIpQLSeT363rMcWNCmiyyGKzQ8Kkq-XMau-hX9Goj9wN2FU4Q9qMJQ/viewform?usp=sf_link>
or
email [log in to unmask]
Thanks so much for your interest!
Conor Douglas (York University, Canada)
Paul Martin (University of Sheffield, United Kingdom)
Sarah Wadmann (Danish Center for Social Science Research, Denmark)
Tineke Kleinhout-Vliek (Utrecht University, the Netherlands)
**********************************************************************
1. For general enquires or problems with the list or to CHANGE YOUR EMAIL ADDRESS send a message to:
[log in to unmask]
2. To suspend yourself from the list, whilst on leave, for example,
send an email to [log in to unmask] with the following message:
set medsocnews nomail
3. To resume email from the list, send the following message:
set medsocnews mail
4. To leave MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
leave medsocnews
5. To join or subscribe to MedSocNews, send an email to [log in to unmask] with the message (leave the subject line blank and do not include a signature):
SUBSCRIBE medsocnews firstname lastname
6. Further information about the medsocnews discussion list (including
list archive and how to subscribe to or leave the list) can be found
at the list web site:
http://www.jiscmail.ac.uk/lists/medsocnews.html
**********************************************************************
|